These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16445123)

  • 1. Bringing primary cells to mainstream drug development and drug testing.
    Goldbard S
    Curr Opin Drug Discov Devel; 2006 Jan; 9(1):110-6. PubMed ID: 16445123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A preadipocyte differentiation assay as a method for screening potential anti-type II diabetes drugs from herbal extracts.
    Xu ME; Xiao SZ; Sun YH; Ou-yang Y; Guan C; Zheng XX
    Planta Med; 2006 Jan; 72(1):14-9. PubMed ID: 16450290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery.
    Prestwich GD
    Acc Chem Res; 2008 Jan; 41(1):139-48. PubMed ID: 17655274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel class of Hsp90 inhibitors isolated by structure-based virtual screening.
    Park H; Kim YJ; Hahn JS
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6345-9. PubMed ID: 17869098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of the human tumor stem cell assay to new drug evaluation and screening.
    Salmon SE
    Prog Clin Biol Res; 1980; 48():291-312. PubMed ID: 7193873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragment-based lead discovery: a chemical update.
    Erlanson DA
    Curr Opin Biotechnol; 2006 Dec; 17(6):643-52. PubMed ID: 17084612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of a new bisphosphonate, minodronate, on proliferation and invasion of a variety of malignant bone tumor cells.
    Kubo T; Shimose S; Matsuo T; Tanaka K; Yasunaga Y; Sakai A; Ochi M
    J Orthop Res; 2006 Jun; 24(6):1138-44. PubMed ID: 16705696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryopreserved cells facilitate cell-based drug discovery.
    Zaman GJ; de Roos JA; Blomenröhr M; van Koppen CJ; Oosterom J
    Drug Discov Today; 2007 Jul; 12(13-14):521-6. PubMed ID: 17631245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical appraisal of the "human tumor stem-cell assay".
    Selby P; Buick RN; Tannock I
    N Engl J Med; 1983 Jan; 308(3):129-34. PubMed ID: 6336820
    [No Abstract]   [Full Text] [Related]  

  • 10. Corneal epithelial cell cultures as a tool for research, drug screening and testing.
    Castro-Muñozledo F
    Exp Eye Res; 2008 Mar; 86(3):459-69. PubMed ID: 18191836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-D tumor model for in vitro evaluation of anticancer drugs.
    Horning JL; Sahoo SK; Vijayaraghavalu S; Dimitrijevic S; Vasir JK; Jain TK; Panda AK; Labhasetwar V
    Mol Pharm; 2008; 5(5):849-62. PubMed ID: 18680382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput screening of cell responses to biomaterials.
    Yliperttula M; Chung BG; Navaladi A; Manbachi A; Urtti A
    Eur J Pharm Sci; 2008 Oct; 35(3):151-60. PubMed ID: 18586092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspects of successful drug discovery and development.
    Pauwels R
    Antiviral Res; 2006 Sep; 71(2-3):77-89. PubMed ID: 16828174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of standardized cell culture conditions for tumor cells with potential clinical application.
    Stadler G; Wieser M; Steindl F; Grillari J; Katinger H; Pfragner R; Voglauer R
    Cytotherapy; 2007; 9(5):488-98. PubMed ID: 17786610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of human embryonic stem cell technologies to drug discovery.
    Sartipy P; Björquist P; Strehl R; Hyllner J
    Drug Discov Today; 2007 Sep; 12(17-18):688-99. PubMed ID: 17826681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbioreactors for high-throughput cytotoxicity assays.
    Yang ST; Zhang X; Wen Y
    Curr Opin Drug Discov Devel; 2008 Jan; 11(1):111-27. PubMed ID: 18175274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The activity of zoledronic Acid on neuroblastoma bone metastasis involves inhibition of osteoclasts and tumor cell survival and proliferation.
    Peng H; Sohara Y; Moats RA; Nelson MD; Groshen SG; Ye W; Reynolds CP; DeClerck YA
    Cancer Res; 2007 Oct; 67(19):9346-55. PubMed ID: 17909043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indirect antitumor effects of bisphosphonates on prostatic LNCaP cells co-cultured with bone cells.
    Tanaka T; Kawashima H; Ohnishi K; Matsumura K; Yoshimura R; Matsuyama M; Kuratsukuri K; Nakatani T
    Anticancer Res; 2009 Apr; 29(4):1089-94. PubMed ID: 19414350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.